Skip to content

AcrySof™ IQ Vivity™ DFT615 (REF DFT615.125)Recalls & reported problems

Alcon Laboratories, Inc. · STERILE UV AND BLUE LIGHT FILTERING ACRYLIC FOLDABLE ASPHERIC X-WAVE™ POSTERIOR CHAMBER INTRAOCULAR LENS · Class 3 · Implant

All models of AcrySof IQ Vivity (225)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380652423137), received between Mar 11, 2022 and May 28, 2025 — classified as 2 injuries.

The most frequently reported specific device problem is “Failure to Align” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Failure to Align1

Patient problems

  • Blurred Vision1
  • Insufficient Information1
  • Visual Impairment1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 28, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PHYSICIAN REPORTED THAT AFTER SURGERY THE PATIENT HAS EXPERIENCED A POST-OPERATIVE ASTIGMATISM WITH 2.5 DIOPTERS. ADDITIONALLY, PATIENT ALSO HAD HER BLURRED VISION DUE TO THE HUGE AMOUNT OF RESIDUAL ASTIGMATISM. THE WHOLE PLAN (BIOMETRY., ETC.) OF THE SURGERY HAS BEEN DONE WITH A PROPERLY CALIBRATED WITH COMPANY BIOMETRY. ALTHOUGH POSTOPERATIVELY THE PATIENT NEEDS GLASSES IN ORDER TO CORRECT THIS RESIDUAL ASTIGMATISM. POST OPERATIVELY EXAMINATION SHOWN THAT NO ROTATION AND NO DECENTRATION OF THE INTRAOCULAR LENS (IOL) AND THERE WAS NO IMPACT TO THE PATIENT. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Blurred Vision; Visual Impairment

    MAUDE report 22096872 ↗
  • InjuryMar 11, 2022Failure to Align; Failure to Align

    A PHYSICIAN REPORTED FOLLOWING AN INTRAOCULAR LENS IMPLANT PROCEDURE, THE LENS HAS ROTATED FROM 105 DEGREES TO 60 DEGREES. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND RECEIVED WHICH CONFIRMS THE LENS WAS EXPLANTED IN A SECONDARY PROCEDURE.

    Patient problems: Insufficient Information

    MAUDE report 13734821 ↗

Other Extended depth of focus intraocular lens devices

All Extended depth of focus intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page